Literature DB >> 16996388

Industry evolution through consolidation: Implications for addiction treatment.

Rafael A Corredoira1, John R Kimberly.   

Abstract

Drawing on experiences in other industries, this article argues that the business of addiction treatment is likely to be transformed by the advent of a period of consolidation, in which a number of small independent programs will be acquired by larger, better capitalized, and managerially more sophisticated enterprises. Consolidation will be driven by opportunities to leverage new technologies, to exploit new regulatory initiatives, and to introduce economies of scale and scope into an industry that is currently highly fragmented. The process is likely to result in segmentation of the market, with the coexistence of large, generalist, highly standardized firms and a number of small highly specialized firms. When an industry consolidates, the types and quality of services provided can improve through the adoption of best practices and through increased competition among larger providers. If these larger providers are publicly traded, however, efforts to improve will inevitably be influenced by pressures to maintain or increase quarter-to-quarter earnings and share prices, leaving open the long-term impact on service quality.

Mesh:

Year:  2006        PMID: 16996388     DOI: 10.1016/j.jsat.2006.06.020

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  5 in total

1.  Influence networks among substance abuse treatment clinics: implications for the dissemination of innovations.

Authors:  Kimberly Johnson; Andrew Quanbeck; Adam Maus; David H Gustafson; James W Dearing
Journal:  Transl Behav Med       Date:  2015-09       Impact factor: 3.046

2.  Community context and healthcare quality: the impact of community resources on licensing and accreditation of substance abuse treatment agencies.

Authors:  Matthew E Archibald; Caddie Putnam Rankin
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

3.  A business case for quality improvement in addiction treatment: evidence from the NIATx collaborative.

Authors:  Andrew R Quanbeck; Lynn Madden; Eldon Edmundson; James H Ford; K John McConnell; Dennis McCarty; David H Gustafson
Journal:  J Behav Health Serv Res       Date:  2012-01       Impact factor: 1.505

4.  Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions.

Authors:  Lena Lundgren; Ivy Krull; Lisa de Saxe Zerden; Dennis McCarty
Journal:  Eval Program Plann       Date:  2011-03-10

5.  What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations.

Authors:  Kyle L Grazier; Andrew R Quanbeck; John Oruongo; James Robinson; James H Ford; Dennis McCarty; Alice Pulvermacher; Roberta A Johnson; David H Gustafson
Journal:  J Healthc Qual       Date:  2015 Nov-Dec       Impact factor: 1.095

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.